Results 151 to 160 of about 446,586 (304)

Human FcRL5 is an Fc receptor that simultaneously engages two IgGs. [PDF]

Sci Adv
Chen S, Li S, Zhang Z, Xiao J.
europepmc   +1 more source

Cyclodextrin‐Functionalized Light‐Driven Cu2O Micromotors for Simultaneous Capture and Degradation of Bisphenol A

Advanced Robotics Research, EarlyView.
Fuel‐free Cu2O‐based micromotors functionalized with β‐cyclodextrin actively remove bisphenol A from water under visible light. The cyclodextrin shell captures BPA and enhances micromotor motility, leading to faster degradation and higher overall removal than nonfunctionalized Cu2O and Cu2O@Au.
Luisa Natalia Cordoba Urresti, Rebeca Ferrer Campos, Yufen Chen, Katherine Villa   +3 more
wiley   +1 more source

Structure of the human astrovirus capsid spike in complex with the neonatal Fc receptor. [PDF]

Nat Commun
Lentz A, Lanning S, Iranpur KR, Ricemeyer L, Arias CF, DuBois RM.   +5 more
europepmc   +1 more source

Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation. [PDF]

Biochim Biophys Acta Gen Subj, 2023
Bauer-Smith H, Sudol ASL, Beers SA, Crispin M.   +3 more
europepmc   +1 more source

Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy

Advanced Science, EarlyView.
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance, Bryan S. Yung, Michael M. Allevato, Marcus M Cheng, Maria F. Camargo, Robert Saddawi‐Konefka, Kanika Dhawan, Ashwyn K. Sharma, Mahsa Mortaja, Sophie Bice, Daniel J. Scanderbeg, Diego Alvarado, Jyoti Mayadev, Ramez N. Eskander, Stephen R. Adams, Pippa F. Cosper, J. Silvio Gutkind, Sunil J. Advani   +17 more
wiley   +1 more source

Recurrent steroid-intolerant Hashimoto's encephalopathy responsive to single-dose neonatal Fc receptor antagonist: a case report and literature review. [PDF]

BMC Neurol
Wang X, Wang G, Xu J, Bai Y, Yan W, Liu X, Zhang S, Shen R.   +7 more
europepmc   +1 more source

The therapeutic age of the neonatal Fc receptor. [PDF]

Nat Rev Immunol, 2023
Pyzik M, Kozicky LK, Gandhi AK, Blumberg RS.   +3 more
europepmc   +1 more source

PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC

Advanced Science, EarlyView.
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao, Qinyuan Liu, Zhongwei Xin, Zhiyao Zhou, Mingjie Lin, Di Chen, Zhixing Hao, Yongyuan Chen, Wenxuan Wu, Shuyang Zhang, Xiaoke Chen, Xia Xu, Jinfan Li, Wei Lin, Yuhao Lu, Dang Wu, Pin Wu   +16 more
wiley   +1 more source

Nipocalimab-aahu in generalised myasthenia gravis: A new Fc receptor-targeted option for antibody-positive patients. [PDF]

Ibrain
Hussain JM, Ashfaq A, Shahid A, Mudassir F.   +3 more
europepmc   +1 more source

Structural basis for Fc receptor recognition of immunoglobulin M. [PDF]

Nat Struct Mol Biol, 2023
Chen Q, Menon RP, Masino L, Tolar P, Rosenthal PB.   +4 more
europepmc   +1 more source